Modeling Huntington’s disease: An insight on in-vitro and in-vivo models
Behavioural Brain Research · 2024
DOI: 10.1016/j.bbr.2023.114757 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Behavioural Brain Research, 2024. Verfasst von Nitasha Rana und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, ISF College of Pharmacy, Moga 142001, Affiliated to I.K Gujral Punjab Technical University, Jalandhar, Punjab, India. Hauptthemen laut MEDLINE: Huntington Disease. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 142 Literaturangaben.
Abstract (Originalsprache)
Huntington's disease is a neurodegenerative illness that causes neuronal death most extensively within the basal ganglia. There is a broad class of neurologic disorders associated with the expansion of polyglutamine (polyQ) repeats in numerous proteins. Several other molecular mechanisms have also been implicated in HD pathology, including brain-derived neurotrophic factor (BDNF), mitochondrial dysfunction, and altered synaptic plasticity in central spiny neurons. HD pathogenesis and the effectiveness of therapy approaches have been better understood through the use of animal models. The pathological manifestations of the disease were reproduced by early models of glutamate analog toxicity and mitochondrial respiration inhibition. Because the treatments available for HD are quite limited, it is important to have a definite preclinical model that mimics all the aspects of the disease. It can be used to study mechanisms and validate candidate therapies. Although there hasn't been much success in translating animal research into clinical practice, each model has something special to offer in the quest for a deeper comprehension of HD's neurobehavioral foundations. This review provides insight into various in-vitro-and in-vivo models of HD which may be useful in the screening of newer therapeutics for this incapacitating disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, ISF College of Pharmacy, Moga 142001, Affiliated to I.K Gujral Punjab Technical University, Jalandhar, Punjab, India.
- Department of Pharmaceutical Sciences, HNB Garhwal University (A Central University), Chauras Campus, Distt. Tehri Garhwal, Uttarakhand 246174, India.
- Department of Pharmacology, ISF College of Pharmacy, Moga 142001, Affiliated to I.K Gujral Punjab Technical University, Jalandhar, Punjab, India. Electronic address: artiniper@gmail.com.
Zitieren
APA
Rana, N., Kapil, L., Singh, C., & Singh, A. (2024). Modeling Huntington’s disease: An insight on in-vitro and in-vivo models. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2023.114757
Vancouver
Rana N, Kapil L, Singh C, Singh A. Modeling Huntington’s disease: An insight on in-vitro and in-vivo models. Behavioural Brain Research. 2024. doi:10.1016/j.bbr.2023.114757
BibTeX
@article{Rana2024,
author = {Rana, Nitasha and Kapil, Lakshay and Singh, Charan and Singh, Arti},
title = {Modeling Huntington’s disease: An insight on in-vitro and in-vivo models},
journal = {Behavioural Brain Research},
year = {2024},
doi = {10.1016/j.bbr.2023.114757}
}
EUVIMED